Diagnostika a léčba akutního infarktu myokardu s elevacemi ST

Cor et Vasa

Volumn 51, Issue 10, 2009, Pages 724-740

  Widimský, Petr ^a   Hlinomaz, Ota ^a   Kala, Petr ^a   Jirmář, Radovan ^a   Vojáček, Jan ^a   Janoušek, Stanislav ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72449188277     PISSN: 00108650     EISSN: None     Source Type: Journal    
DOI: 10.33678/cor.2009.178     Document Type: Review

References (54)

1. Thygesen K, Alport JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction; Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernández-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibier WB, Goff D, Tubaro M, Dudek D, Al-Attar N. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-2538
2. Montalescot G, Dallongeville J, Van Belle E, et al. STEMI and NSTEMI: Are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA Registry. Eur Heart J 2007;28:1409-17.
3. Schiele F, Legalery P, Didier K, et al. Impact of renal dysfunction on 1-year mortality after acute myocardial infarction. Am Heart J 2006;151:661-667 (Pubitemid 43290257)
4. Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007;297:1892-1900
5. Allen LA, O'Donnell ChJ, Camargo CA. Comparison of long-term mortality across the spectrum of acute coronary syndromes. Am Heart J 2006;151:1065-1071
6. Braunwald E. Acute myocardial infarction: the value of being prepared. N Engl J Med 1996;334:51-52 (Pubitemid 26012508)
7. Brieger D, Eagle KA, Goodman SC, et al. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group. CHEST 2004;126:461-469
8. Widimský P, Janoušek S, Vojáček J. Doporučení pro diagnostiku a léčbu akutního infarktu myokardu. Cor Vasa 2002;44:K123-K143.
9. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verfleugt F, Weidinger F, Weis M; ESC Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Silber S, Aguirre FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Di Mario C, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GY, Rutten F. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-2945
10. European Resuscitation Council guidelines for resuscitation. Resuscitation 2005;67 (Suppl 1):S39-86.
11. COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1622-1632
12. Jerry P, Nolan A, Peter T, Morley B, et al. Therapeutic hypothermia after cardiac arrest. An advisory statement by the Advanced Life Support Task Force of The International Liaison Committee on Resuscitation. Resuscitation 2003;57:231-235
13. Widimský P, Budesínský T, Vorác D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 2003;24:94-104.
14. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS; DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-742 (Pubitemid 37010777)
15. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361(9351):13-20. (Pubitemid 36050955)
16. Svilaas T, Vlaar PJ, van der Horst I, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008;358:557-567 (Pubitemid 351214283)
17. Widimský P, Groch L, Želízko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000;21:823-831
18. Limi Vermeer F, Oude Ophuis A, Van den Berg E, et al. Prospective randomized comparison between thrombolysis rescue PTCA and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: the LIMI study, a safety and feasibility study. Heart 1999;82:431-436 (Pubitemid 29475199)
19. ASSENT-4 PCI investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006;367 (9510):569-578
20. Ellis SG, Tendera M, de Beider MA, van Boven AJ, Widimsky P, Janssens L, Andersen HR, Betriu A, Savonitto S, Adamus J, Peruga JZ, Kosmider M, Katz O, Neunteufl T, Jorgova J, Dorobantu M, Grinfeld L, Armstrong P, Brodie BR, Herrmann HC, Montalescot G, Neumann FJ, Effron MB, Barnathan ES, Topol EJ; FINESSE Investigators. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008;358:2205-2217 (Pubitemid 351724450)
21. Freemantle N, Cleland J, Young P, et al. Beta blockade after myocardial infarction: systemic review and meta regression analysis. Br Med J 1999; 318:1730-1737 (Pubitemid 29290470)
22. Vaverková H, Soška V, Rosolová H, et al. Doporučení pro diagnostiku a léčbu dyslipidemiǐ v dospělosti, vypracované výborem České společnosti pro aterosklerózu.Vnitř Lék 2007;53:181-197
23. ISIS-4. A randomised factorial trial assessingearly oral captopril, oral mononitrate, and intravenous magnesium in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995;345:669-685
24. Chinese Cardiac Study Collaborative Group. Oral captopril versus placebo among 13,634 patients with suspected myocardial infarction: interim report from the Chinese Cardiac study (CCS-1). Lancet 1995;345:686-687
25. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology and of the European Association for the Study of Diabetes. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. Eur Heart J 2007;28:88-136.
26. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005;26:650-661 (Pubitemid 40516876)
27. Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acute coronary syndrome. A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008;117:1610-1619
28. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003;42:1050-1065 (Pubitemid 37413751)
29. Newby KH, Thomson T, Stebbins A, et al. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. Circulation 1998;98:2567-2573
30. Chockalingam A, Gnanavelu G, Subramaniam T, Dorairajan S, Chockalingam V. Right ventricular myocardial infarction: presentation and acute outcomes. Angiology 2005;56:371-376 (Pubitemid 41040520)
31. Hreybe H, Singla I, Razak E, et al. Predictors of Cardiac Arrest Occurring in the Context of Acute Myocardial Infarction. Pacing Clin Electrophysiol 2007;30:1262-1266 (Pubitemid 47493129)
32. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation 2008;117:103-114
33. Lalonde L, Ziadi MC, Beanlands R. Cardiac positron emission tomography: current clinical practice. Cardiol Clin 2009;2:237-255
34. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453 (Pubitemid 30832880)
35. Bytešník J. Doporučené postupy pro diagnostiku a léčbu komorových arytmií. Cor Vasa 2005;47 (Suppl):41-57.
36. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 2003;138:445-452
37. Táborský M, Kautzner J, Bytešník J, a spol. Doporuieni pro implantace kardiostimulátorů, ICD a srdeční resynchronizační léčbu. Cor Vasa 2005;47 (Suppl):59-68.
38. http://www.kardio-cz.cz
39. Menon V, Pearte CA, Buller CE, et al. Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial. Eur Heart J 2009;30:183-189
40. The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008;29:2388-2442
41. Želízko M. Akutní infarkt myokardu s elevacemi ST úseku: Realita - výsledky registru NRKI. XV. výroč ní sjezd České kardiologické společnosti. Brno, 14. 5. 2007.
42. Hochman JS, Sleeper LA, White HD, et al. One-year survival following early revascularization for cardiogenic shock. JAMA 2001;285:190-192 (Pubitemid 32048521)
43. Leshnower BG, Gleason TG, O'Hara ML, et al. Safety and efficacy of left ventricular assist device support in postmyocardial infarction cardiogenic shock. Ann Thorac Surg 2006;81:1365-70; discussion 1370-1371
44. Thiele H, Smalling RW, Schuler GC. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2007;28:2057-2063 (Pubitemid 47517433)
45. Chen Q, Darlymple-Hay MJ, Alexiou C, et al. Mitral valve surgery for acute papillary muscle rupture following myocardial infarction. Heart Valve Dis 2002;11:27-31. (Pubitemid 36957799)
46. European Resuscitation Council guidelines for resuscitation. Resuscitation 2005;67 (Suppl 1):S39-86.
47. Goldstein JA, Lee DT, Pica MC, et al. Patterns of coronary compromise leading to bradyarrhythmias and hypotension in inferior myocardial infarction. Coran Artery Dis 2005;16:265-274
48. Studenčan M. Akutní koronární syndrom. Olomouc: Sport Media Group, 2007:123-124
49. AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update. J Am Coll Cardiol 2006;47:2130-2139
50. Winkelmayer WC, Setoguchi S, Levin R, Solomon DH. Comparison of Cardiovascular Outcomes in Elderly Patients With Diabetes Who Initiated Rosiglitazone vs Pioglitazone Therapy. Arch Intern Med 2008;168:2368-2375
51. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007;28:88-136.
52. AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update. J Am Coll Cardiol 2006;47:2130-2139
53. Chaloupka V, Siegelová J, Špinarova L, et al. Rehabilitace u nemocných s kardiovaskulárním onemocněním. Cor Vasa 2006;48:K127-K145.
54. Jirmář R, Nehyba S. Doporučení pro posudkovou činnost v kardiologii. Cor Vasa 1999;41:K178-K184.